Stockreport

Amicus Therapeutics Inc (FOLD) Reports 21% Revenue Growth in 2023, Eyes Non-GAAP Profitability ... [Yahoo! Finance]

Amicus Therapeutics, Inc.  (FOLD) 
Last amicus therapeutics, inc. earnings: 11/11 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.amicusrx.com/investor-relations
PDF Net Loss: Reduced to $151.6 million in 2023 from $236.6 million in 2022. Non-GAAP Profitability: Anticipated for the full year of 2024, reflecting operational efficie [Read more]